• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

PILMA

Pharmaceutical Industry Labor-Management Association

GET THE LATEST
  • Home
  • Who We Are
    • About PILMA
    • Trustees
    • Partners
    • Mission Statement
  • What We Do
    • Partnership for Life
    • My Tools, Your Health
    • Saving Money, Saving Lives
    • Progress Through Collaboration
    • Continuous Partners
  • News & Resources
    • America’s Best, Saving America
    • Union Jobs Report
    • PILMA News
    • Stories
      • Union Jobs Report
      • Maryland Senator Hollen Tours IBEW Local 26
      • Smart Local 19
    • Resolutions
    • Reports
    • Video Gallery
      • Facility Tours
  • Contact Us

Statement on Section 232 Investigations into Pharmaceuticals 

May 7, 2025


The Pharmaceutical Industry Labor-Management Association (PILMA) supports policies that strengthen America’s national security, protect public health, and promote innovation and high-quality job growth in the pharmaceutical industry. As such, any use of Section 232 investigations into pharmaceutical products must be carefully tailored to focus strictly on legitimate national security concerns and patients’ health. Section 232 is a powerful tool intended to safeguard national security, not to disrupt the critical manufacturing base that supports the health and economic well-being of the United States. We urge policymakers to ensure that such investigations do not undermine the U.S. pharmaceutical supply chain or threaten the jobs of the American workers who manufacture essential medicines and treatments. Strong domestic manufacturing is a cornerstone of both national security and public health. America’s pharmaceutical workforce is vital to ensuring access to safe, effective medications and maintaining our healthcare system’s resilience. Therefore, any actions taken under Section 232 must avoid unintended consequences that could weaken American production, jeopardize good jobs, or limit access to life-saving treatments. PILMA remains committed to advancing policies that balance security with economic growth and support the hardworking men and women whose labor drives American innovation and safeguards our nation’s health. 

Download the statement here

Filed Under: News

Primary Sidebar

22.3

MILLION

Union hours supported by the pharmaceutical industry

$774

MILLION

in wages

Footer

  • Contact Us
  • Who We Are
    • About PILMA
    • Trustees
    • Partners
    • Mission Statement
  • What We Do
    • Partnership for Life
    • My Tools, Your Health
    • Saving Money, Saving Lives
    • Progress Through Collaboration
    • Continuous Partners
  • News & Resources
    • Union Jobs Reports
    • PILMA News
    • Resolutions
    • Video Gallery
    • Facility Tours

© 2025 PILMA. All Rights Reserved.
Home | Contact Us | Privacy Policy